Re: The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men

Samir S. Taneja

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)127
Number of pages1
JournalThe Journal of urology
Volume193
Issue number1
DOIs
StatePublished - Jan 1 2015

ASJC Scopus subject areas

  • Urology

Cite this